Tempest Therapeutics, Inc.
TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31
Reports and events: 303 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-114376 |
| 2026-10-2616:05 ET | DEF 14A | Proxy statementPeriod 2026-11-09 | 0001213900-26-112476 |
| 2026-10-2016:06 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001213900-26-111026 |
| 2026-10-1916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-110669 |
| 2026-09-2816:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-104034 |
| 2026-09-1717:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-394492 |
| 2026-09-1616:37 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-393151 |
| 2026-09-1516:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-391903 |
| 2026-08-2416:43 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-363695 |
| 2026-08-2116:46 ET | S-1 | Registration statement | 0001193125-26-361240 |
| 2026-08-1816:27 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-355550 |
| 2026-08-1316:37 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349381 |
| 2026-08-1316:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349374 |
| 2026-08-1316:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-349334 |
| 2026-07-2816:50 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-321176 |
| 2026-07-2216:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-312391 |
| 2026-07-1716:32 ET | DEF 14A | Proxy statementPeriod 2026-07-27 | 0001140361-26-028823 |
| 2026-06-2320:22 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-278068 |
| 2026-06-0816:06 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001140361-26-024453 |
| 2026-06-0417:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-257684 |
| 2026-06-0219:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-251994 |
| 2026-05-2917:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-248648 |
| 2026-05-2217:28 ET | 8-K | 3.01 Delisting notice | 0001193125-26-237207 |
| 2026-05-2217:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-237150 |
| 2026-05-1417:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224289 |
| 2026-05-1416:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224156 |
| 2026-05-0607:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-207601 |
| 2026-04-0216:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-140271 |
| 2026-03-3008:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-130490 |
| 2026-03-3008:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-130480 |
| 2026-03-2517:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001931356-26-000013 |
| 2026-03-2308:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-118618 |
| 2026-02-2508:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-068614 |
| 2026-02-1107:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-045543 |
| 2026-02-1017:15 ET | SCHEDULE 13D | Ownership report, active investor | 0001931356-26-000009 |
| 2026-02-0616:12 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-041190 |
| 2026-01-2816:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-027203 |
| 2026-01-0916:15 ET | 8-K | 3.01 Delisting notice | 0001193125-26-008938 |
| 2025-12-3116:15 ET | DEF 14A | Proxy statementPeriod 2026-01-27 | 0001140361-25-047054 |
| 2025-12-0916:51 ET | S-1 | Registration statement | 0001193125-25-312887 |
| 2025-11-2608:55 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-298604 |
| 2025-11-1909:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-287163 |
| 2025-11-0509:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-265946 |
| 2025-11-0509:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265937 |
| 2025-08-1319:14 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-108261 |
| 2025-08-1116:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106558 |
| 2025-08-1116:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106544 |
| 2025-06-1216:18 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-139899 |
| 2025-06-1107:41 ET | 8-K | 8.01 Other events | 0001193125-25-138802 |
| 2025-06-0616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-137041 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:12 ET. Listed shows no prices and gives no investment advice.